𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A renal cell carcinoma neoplastic antigen detectable by immunohistochemistry is defined by a murine monoclonal antibody

✍ Scribed by John Kochevar


Publisher
John Wiley and Sons
Year
1987
Tongue
English
Weight
515 KB
Volume
59
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Identification of a surface antigen, com
✍ Eran Hadas; Esther Hurwitz; Zelig Eshhar πŸ“‚ Article πŸ“… 1984 πŸ› John Wiley and Sons 🌐 French βš– 696 KB

## Abstract Lewis lung carcinoma (3LL) is a spontaneous murine lung carcinoma which preferentially metastasizes into the lung. Monoclonal antibodies (MAb) against 3LL cells were prepared by fusing spleen cells from rats immunized with 3LL and the P3‐NSI/I‐Ag4 (NSI) plasmacytoma. Two hybridomas were

Induction of tumor-cell lysis by bi-spec
✍ J. Van Duk; S. O. Warnaar; J. D. H. Van Eendenburg; M. Thienpont; E. Braakman; J πŸ“‚ Article πŸ“… 1989 πŸ› John Wiley and Sons 🌐 French βš– 644 KB

## Bi -specific monoclonal antibodies (MAbs) were developed by somatic hybridization of 2 mouse hybridomas, one producing MAb against the G250 renal-cell carcinoma (RCC)-associated antigen and the other against the T-cell antigen CD3 (OKT3). The dual specificity of the hybrid MAb produced by these

Eradication of established renal cell ca
✍ Seong-A Ju; Sang-Hyeon Cheon; Sang-Min Park; Nyuen Quang Tam; Young Min Kim; Won πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 French βš– 904 KB

## Abstract Renal cell carcinoma (RCC), one of the most incurable malignancies, is highly resistant to chemotherapy and radiotherapy. Cytokine immunotherapy has been the standard approach, but the overall response rate is still very low. Administration of agonistic anti‐4‐1BB monoclonal antibody (m

Mutated cytochrome b as a determinant of
✍ Anita Choudhary; Robert A. Kurt; FranΓ§oise Goret; Anne Moreau; Elisabeth DiΓ©z; W πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 French βš– 250 KB

We generated a monoclonal antibody (MAb), H8.98, that recognizes an antigen shared by 50% of examined renal carcinoma cell (RCC) lines and is susceptible to lysis by a Vβ₯3V␦1 Ψ‰ T-cell clone derived from RCC tumor-infiltrating lymphocytes. H8.98 inhibited Vβ₯3V␦1 Ψ‰ T-cell clone-mediated lysis of RCC l